Table 2. Immunostaining score and percentage of cells with GLI1-positive nuclear or cytoplasm in normal endometrium and ectopic endometrium (GLI1 immunostaining score).
| Endometrium | Number (%) |
|---|---|
| Normal endometrium | |
| Cases | 31 |
| Nucleus* | 0 (0) |
| Cytoplasm | 18 (58.1) |
| Negative | 13 (41.9) |
| Immunostaining score** | 2.640±1.313 |
| Ectopic endometrium | |
| Cases | 30 |
| Nucleus | 21 (70.0) |
| Nucleus and cytoplasm | 8 (26.7) |
| Negative | 1 (3.3) |
| Immunostaining score | 11.742±1.015 |
*, normal endometrium nuclear GLI1 expression versus ectopic endometrium nuclear GLI1 expression; **, normal endometrium nuclear plus cytoplasm GLI1 expression versus ectopic endometrium nuclear plus cytoplasm GLI1 expression. *, P<0.05; **, P<0.01. All data are expressed as mean ± SD. Statistical significance (Student’s t-test analysis).